Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6070186 | Journal of the American Academy of Dermatology | 2016 | 8 Pages |
Abstract
An assessment of different melanocyte fractions in the diagnostic baseline biopsy specimen may help to predict the response of LM to imiquimod therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mirja MD, Patrick A. MD, Marc MD, Karolina MD, Nikhil MD, Robert E. MD, PhD,